We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0LKB market cap is 952.15M. The company's latest EPS is USD 0.0436 and P/E is 105.73.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 227.19M | 248.17M | 268.68M | 254.38M | 192.64M |
| Operating Income | 22.81M | 27.24M | 42.17M | 6.33M | -13.95M |
| Net Income | 115.55M | 23.34M | 33.15M | 6.28M | 2.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 483.75M | 533.46M | 593.79M | 634.25M | 648.44M |
| Total Liabilities | 72.8M | 80.19M | 88.86M | 107.05M | 103.53M |
| Total Equity | 410.95M | 453.27M | 504.93M | 527.2M | 544.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 45.95M | 51.78M | 64.21M | 31.98M | 12.8M |
| Investing | -68.31M | -41.5M | -76.7M | 49.93M | -12.06M |
| Financing | 6.26M | 5.63M | 3.55M | 734k | N/A |
| Market Cap | 952.15M |
| Price to Earnings Ratio | 105.73 |
| Price to Sales Ratio | 1.38 |
| Price to Cash Ratio | 1.95 |
| Price to Book Ratio | 0.49 |
| Dividend Yield | - |
| Shares Outstanding | 57.53M |
| Average Volume (1 week) | 7.09k |
| Average Volume (1 Month) | 35.8k |
| 52 Week Change | 0.00% |
| 52 Week High | 16.55 |
| 52 Week Low | 16.55 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Vanda Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vandapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
